semaglutide and heart disease Beyond obesity: Novo's SELECT re-defines cardiovascular risk management Semaglutide may reduce heart events

Beta Alanine increases carnosine synthesis

IV Therapy is a cutting-edge way to get a quick energy increase without the jitters or side effects

Hu et al., FAK and paxillin dynamics at focal adhesions in the protrusions of migrating cells, Sci

This is why addressing menopause-related metabolic changes is essential for longevity

Together, we build a personalized treatment plan designed specifically for your body and physiology, not a one-size-fits-all treatment protocol

As primary substrates for DPP-IV are GLP-1, GLP-2, and gastro-insulinotropic peptide (GIP), DPP-IV gene-deficient mice show improved postprandial glucose control and are resistant to progression of obesity and hyperinsulinemia (Drucker 2002